Genetic Heterogeneity in Corpus Callosum Agenesis
Overview
Authors
Affiliations
The corpus callosum is the largest white matter structure connecting the two cerebral hemispheres. Agenesis of the corpus callosum (ACC), complete or partial, is one of the most common cerebral malformations in humans with a reported incidence ranging between 1.8 per 10,000 livebirths to 230-600 per 10,000 in children and its presence is associated with neurodevelopmental disability. ACC may occur as an isolated anomaly or as a component of a complex disorder, caused by genetic changes, teratogenic exposures or vascular factors. Genetic causes are complex and include complete or partial chromosomal anomalies, autosomal dominant, autosomal recessive or X-linked monogenic disorders, which can be either or inherited. The extreme genetic heterogeneity, illustrated by the large number of syndromes associated with ACC, highlight the underlying complexity of corpus callosum development. ACC is associated with a wide spectrum of clinical manifestations ranging from asymptomatic to neonatal death. The most common features are epilepsy, motor impairment and intellectual disability. The understanding of the genetic heterogeneity of ACC may be essential for the diagnosis, developing early intervention strategies, and informed family planning. This review summarizes our current understanding of the genetic heterogeneity in ACC and discusses latest discoveries.
How should antenatal counseling be given to parents in the fetal corpus callosum agenesis?.
Sut H, Yildiz G BMC Pregnancy Childbirth. 2025; 25(1):260.
PMID: 40057705 PMC: 11889785. DOI: 10.1186/s12884-025-07357-x.
Lanzarone V, Eixarch E, Borrell A J Ultrasound Med. 2025; 44(4):637-652.
PMID: 39831641 PMC: 11892088. DOI: 10.1002/jum.16639.
The Genetic Architecture of the Human Corpus Callosum and its Subregions.
Bhatt R, Gadewar S, Shetty A, Ba Gari I, Haddad E, Javid S bioRxiv. 2024; .
PMID: 39091796 PMC: 11291056. DOI: 10.1101/2024.07.22.603147.
Fetal agenesis of corpus callosum: chromosomal copy number abnormalities and postnatal follow-up.
Cai M, Lin N, Fu M, Que Y, Huang H, Xu L Mol Biol Rep. 2024; 51(1):872.
PMID: 39080034 PMC: 11289215. DOI: 10.1007/s11033-024-09821-x.
Wu F, Chen C J Med Ultrasound. 2024; 32(2):99-103.
PMID: 38882617 PMC: 11175368. DOI: 10.4103/jmu.jmu_49_23.